Invent: Health

There is now a widespread awareness of the gravity of mental health issues in the general public, and equally in the world of healthcare. But in tandem with its rise we've seen the growth of the so-called "wellness industry", which too often promotes pseudo scientific solutions to the most complex of problems. So how is the health tech industry responding? What are the new frontiers for digital therapeutic care today, especially in the post-pandemic landscape?

Find out on this week's episode of Invent: Health from TTP

This Week's Guests

Adonis Bou Chakra is the Co-founder & CPO at Aepsy - designing & building products for better minds. He is a former global Design manager at Sennheiser with an MA Digital Management at Hyper Island.
https://www.adonisbc.com/

Dr. Rashmi Patel is a MRC UKRI Health Data Research UK Fellow in the Department of Psychosis Studies at the Institute of Psychiatry, Psychology & Neuroscience, King's College London. He has a particular interest in the neurobiology of psychotic disorders and the role of health data research techniques such as extracting data from free text electronic health records (EHRs) using natural language processing to predict clinical outcomes and develop more effective treatment strategies.
https://www.kcl.ac.uk/people/dr-rashmi-patel

Jordan Abdi is the Strategy and Business Development Lead at Holmusk, a company building the largest Real-World Evidence platform, starting with behavioral health. He is also a World Economic Forum Global Shaper and a Schwarzman Scholar, who is passionate about preventative health. A medical doctor by background, he has close to a decade's experience working in the health technology sector.
https://www.linkedin.com/in/jordanabdi/

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here.
https://ttp.com/invent

Neurotech: what is it? Elon Musk’s brain implants that herald a dystopian sci fi future? Or life saving technology which will be able to cure a multitude of injuries: back pain, epilepsy, even paralysis. In this episode of Invent: Health, we take a look at the hype vs the reality in the thrilling field of neurotech, speaking to experts from TTP and beyond to break it down and find out about its history, its current applications and the incredible places it’s going in the future.

Find out more on this week's episode of Invent: Health from TTP.

This Week's Guests
Dr. Hannah Claridge is a Neural Interfaces specialist who co leads the neurotechnology team here at TTP. After a Master’s degree in Physics and a Ph.D. in Clinical Neurosciences from the University of Oxford, Hannah now specialises in neurotechnology and biosensing, developing clinical technologies for some of the world’s largest Med Tech companies and ambitious startups.
https://www.linkedin.com/in/hannah-claridge

Dr Benjamin Metcalfe is an Assistant Professor at the University of Bath and a co-founder of the Centre for Biosensors, Bioelectronics, and Biodevices – the largest research centre of its type in England. Since starting in this role in 2016 he has published over 40 peer reviewed research papers and co-authored two books on neural interfaces. He holds a number of internal and external posts including as a trustee and non-executive director of both the Institute for Physics and Engineering in Medicine and the charity Designability. His research interests are in the areas of neural interfaces, neural computing, and signal processing.
https://researchportal.bath.ac.uk/en/persons/benjamin-metcalfe

Dr. Chris Dawson co leads the neurotechnology team at TTP with Hannah, working with ambitious clients across this field to develop novel enabling technologies and applying these to medical device development to help bring innovative new products to market. His degree and PhD are in mechanical engineering, and started his career working to develop automation systems to improve development and productivity in life science research, before moving into motorsport and working in the aero department at McLaren to design, develop, and test the aerodynamic elements of their formula one race car. This fast-paced design-develop-deploy environment was great preparation for moving into technology development at TTP, using deep science and engineering expertise to support clients in commercialising their ideas.
https://www.linkedin.com/in/chris-dawson-96908268/

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent

Of all the senses, sight is perhaps our most important. The eye is one of the most incredible organs in nature: it enables us to perceive the world around us, understanding our world through images. And yet we only see a small aspect of reality. But the eye is important beyond just sight. It can also provide a window into our overall health, showing indicators for other things like alzeihmers and blood pressure. In this episode of Invent Health we breakdown the world of modern eyecare to find the ways that tech is improving our collective vision. We’ll hear about preventative procedures, cures to restore sight and the global discrepancies in treatment, alongside really getting to grips with what the future of healthcare looks like for perhaps our most vital organs.

Find out on this week's episode of Invent: Health from TTP.

This Week's Guests
Dr Jose-Alain Sahel is currently the chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, director of the UPMC Eye Center, and the Eye and Ear Foundation Chair of Ophthalmology. Dr. Sahel previously led the Vision Institute in Paris, a research centre associated with the one of the oldest eye hospitals in Europe. He is a pioneer in the field of artificial retina and eye regenerative therapies and a member of the French Academy of Sciences.
https://en.wikipedia.org/wiki/Jos%C3%A9-Alain_Sahel

Pearse Keane is a consultant ophthalmologist at Moorfields Eye Hospital, London, and an associate professor at UCL Institute of Ophthalmology. In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the commonest cause of blindness in many countries. In October 2019, he was included on the Evening Standard Progress1000 list of most influential Londoners and in 2020 he was listed on the “The Power List” by The Ophthalmologist magazine, a ranking of the Top 100 most influential people in the world of ophthalmology.
https://www.linkedin.com/in/pearse-keane-27074a6

Catherine Wyman is a mechanical engineer by background who has developed a variety of medical devices and now leads TTP's eyecare team. She and the team focus on addressing unmet needs across ophthalmology, including in the areas we are discussing today.
https://www.linkedin.com/in/catherinewyman1

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent

Humans are designed to make decisions in the now, not ones in the abstract long term. That’s why ‘cathedral thinking’ comes so hard to us - so it's understandable that making healthcare more sustainable is hard when its primary function is first and foremost to save lives today, not the planet tomorrow. It's easy to say you want to be more sustainable but when you're dealing with people's lives, does sustainability go out of the window? So what can we actually do? This episode of Invent: Health sees us explore the difficulties and challenges as healthcare industries try to become more sustainable.

Find out on this week's episode of Invent: Health from TTP.

This Week's Guests
Dr Michael Spiro is an anaesthetic and intensive care consultant at a London NHS teaching hospital. He has research interests in resource utilisation, enhanced recovery, innovation and sustainability in health care.
https://www.linkedin.com/in/mike-spiro-b40a3289/

Dr Seema Gandhi is a professor in the department of anaesthesia and the medical director of sustainability at University of California, San Francisco Health System. Trained in India/ UK and the US, she has a global perspective of the practice of medicine and her research focused on decreasing carbon emissions and waste from healthcare. Dr Gandhi is involved in many initiatives focused on Reduction of single use devices, energy consumption and increasing  sustainability focused education among healthcare providers.
https://anesthesia.ucsf.edu/people/seema-gandhi

Maria Koijck is a Dutch artist and activist based in Groningen. Her artistic practise has focused on waste for many years. Whether it’s sculptures made from plastic bottles or tackling the issue of beachside pollution in countries as far afield as Sierra Leone, Maria’s work consistently takes aim at the unsustainable use of plastics while simultaneously opening up questions on how we might solve it. 
https://www.mariakoijck.com/
https://www.youtube.com/watch?v=w28M7wjIr6E

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent

Surgical robotics are all the rage right now. Attracting huge investment from the biggest names in healthcare devices, the use of robots in surgery has the potential to change the industry in some really profound and exciting ways. However, some have criticised their implementation as an unnecessary expense when humans can perform these tasks just as well. This episode of Invent: Health will see our guests debate the efficacy and effectiveness of surgical robotics, seeing whether it’s the future of surgery, or just tech for tech’s sake. We’ll also look to the future to see how big an impact this is going to have in the coming years.

Find out on this week's episode of Invent: Health from TTP.

This Week's Guests
Dr. Paul Galluzzo has worked at TTP for the past 18 years. Before that, he did a PhD in mechanical engineering at Cambridge included building a robot to play the cello very accurately. Since then, he has worked across a wide range of markets and products at TTP, from gardening tools to DNA sequencing to inkjet.  Inkjet was a fruitful pathway into ultrasound imaging, and ultrasound was in turn a gateway into medical technology about ten years ago. He now specialises mostly in the technology enablers in med-tech: navigation, visualisation, critical structure detection, energy delivery, implants, and of course surgical robotics.
https://www.linkedin.com/in/paul-galluzzo-1132113/

Dr. Dwight Meglan, whose doctorate is in Mechanical Engineering, has worked on complex medical systems for more than 25 years as part of teams at a number of high technology medical startups as well as major medical device companies. As a result, he has worked on eight commercial surgical robots (NOTES, abdominal/thoracic, endovascular, electrophysiology, cardiac, gastrointestinal), multiple unique medical devices, as well as numerous surgical simulators combining real-time computational physics, VR/AR displays and custom haptics interfaces. His early work was in orthopedic biomechanics at Ohio State with a postdoc at Mayo Clinic where he turned down a tenure track position so he could stay involved in hands-on work.
https://www.linkedin.com/in/dmeglan/

Dr. Mark Slack is the Chief Medical Officer and one of the co-founders of CMR Surgical, a global surgical robotics company that has developed Versius, a next-generation robotic system used to perform keyhole surgery. Today, Versius is being used in routine clinical practice to deliver high quality surgical care to patients around the world. Mark qualified in Medicine from the University of the Witwatersrand, Johannesburg and completed his postgraduate training in Obstetrics & Gynaecology at the University of Cape Town. During this time he was awarded the prestigious Daubenton Gold Medal from the College of Medicine of South Africa. Mark established the Urogynaecology service at Addenbrooke’s Hospital which has recognised accreditation by the British Society of Urogynaecology. He is also on the Editorial Board for the journal 'BMJ Surgery, Innovation and Health Technology'. He is a Fellow of the Royal College of Obstetricians and Gynaecologists and an official spokesperson for the college.

https://www.linkedin.com/in/mark-slack-3b8a2139/

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/

Healthcare’s coming home, it’s coming home… Or is it? Recent years - and increasingly since COVID 19 - have seen healthcare moving into the home, with patients using more digital products to track their health from the comfort of their sofas. But why? What was the initial trigger for this? What are the risks and benefits? Will this see a dystopian world where only the rich see doctors in person or a complete democratisation of convenient healthcare? In this episode of Invent Health we break down healthcare in the home to see the benefits and blockers in the now and in the future.

Find out on this week's episode of Invent: Health from TTP.

This Week's Guests
Clayton Poppe is the CTO of Diality. From their base in California, Diality is redefining home dialysis, enabling patients in Kidney failure to undergo hemodialysis, in their own home. An engineer  and technical management professional by background, Calyton specializes in new product and technology development and process scale-up.
https://www.linkedin.com/in/claytonpoppe/

Alex Gilbert has worked within the Digital Health Industry for a number of years alongside healthcare, pharmaceutical and tech organisations. He joined Huma (previously called Medopad) as one of their first employees and currently manages global Life Sciences Partnerships and Digital Medicine development. Huma is one of the UK’s highest-growth digital health companies, having raised over 50 Million in funding, whilst partnering with Apple and Tencent. His passion is the use of technology to empower and engage the patient to take control of their care.
https://www.linkedin.com/in/alexgilberthuma/

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/

What is pain? Where does it start and end? In the mind, nerve endings, or somewhere else? In this final episode of the first season of Invent: Health from TTP, we’ll be exploring the many and varied facets of this most essential of human experiences. Speaking with specialists in the fields of psychology and neuroscience, we’ll find out what is being done to measure pain, to mitigate its severity and what the future of pain relief looks like, to see if people involved in healthcare and drug delivery should be giving pain more attention in their work.

Find out more on this week's episode of Invent: Health from TTP.

This Week's Guests
Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.
https://www.linkedin.com/in/danlock/

Dr. Hannah Claridge is a Neural Interfaces specialist here at TTP who, after a Master’s degree in Physics and a Ph.D. in Clinical Neurosciences from the University of Oxford, now specialises in neurotechnology and biosensing, developing clinical technologies for some of the world’s largest Med Tech companies and ambitious startups.
https://www.linkedin.com/in/hannah-claridge

Dr. David Cottenden is a consultant here at TTP. He holds a Masters Degree in Mathematics from Cambridge University and a PHD in biomechanics from UCL. David's work has encompassed everything from developing medical devices to exploring and mapping pain in drug delivery.
https://www.linkedin.com/in/david-cottenden-7661b64b/

The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://www.ttp.com/

Hello and welcome to Invent: Health, a podcast from technology and product development company TTP.

Invent: Health is a podcast about the future of health and technology, hosted by TTP Design and Strategy consultant, Matt Millington. Each week, we’ll be joined by the top scientists, designers, business leaders and academics working at the vanguard of this vital industry, to give you a behind-the-scenes look at the world of health tech.

See you soon!

We’re currently taking a short hiatus after our first season, where we covered everything from curing blindness to controlling pain; from making hospitals more sustainable to putting a hospital in your home. Before we come back with season two, our friends over at the Life Sciences team here at TTP are going to be dropping their very own series in the new year. 

Invent: Life Sciences will be a series looking at all things biology - the efficacy of animal testing, the benefits of synthetic biology, even asking what the infamous team behind Theranos actually got right in terms of diagnostics. 

But in the meantime, we wanted to give you some bonus content to whet your appetite for things to come and spread a bit of Christmas cheer. So here’s the full conversation from one of our favourite interviews of this series. In early November, we spoke with Dr. Pearse Keane for our episode on eyecare, looking at how the world’s top doctors and scientists are working to find ways to restore sight.

Dr. Pearse Keane is a consultant ophthalmologist at Moorfields Eye Hospital, London, and an associate professor at UCL Institute of Ophthalmology. In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the commonest cause of blindness in many countries. In October 2019, he was included on the Evening Standard Progress1000 list of most influential Londoners and in 2020 he was listed on the “The Power List” by The Ophthalmologist magazine, a ranking of the Top 100 most influential people in the world of ophthalmology.
https://www.linkedin.com/in/pearse-keane-27074a6